Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01657682
Title A Phase II Study of Crenolanib in Relapsed/Refractory Acute Myeloid Leukemia Patients With FLT3 Activating Mutations
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Arog Pharmaceuticals LLC
Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST